
51 - 200 employees
π° $140M Series B on 2022-01
Leyden Labs aims to help people live their lives to the fullest. Our platform targets commonalities of viral families to protect humanity from known and future viruses. Our portfolio of accessible intranasal product candidates may provide people with the freedom to immediately protect themselves from and prevent the spread of many variants of respiratory viruses, including ones in the influenza and coronavirus families.
π₯ 3 hours ago
51 - 200
Freelance Sr. Clinical Trial Associate assisting Clinical Trial Teams in the Netherlands with project tracking and document management. Role involves collaboration with internal teams and ensuring compliance with clinical practices.